Journal of Controlled Release, Journal Year: 2023, Volume and Issue: 362, P. 70 - 96
Published: Aug. 29, 2023
Language: Английский
Journal of Controlled Release, Journal Year: 2023, Volume and Issue: 362, P. 70 - 96
Published: Aug. 29, 2023
Language: Английский
Advanced Drug Delivery Reviews, Journal Year: 2023, Volume and Issue: 198, P. 114895 - 114895
Published: May 19, 2023
Language: Английский
Citations
111Chemical Reviews, Journal Year: 2023, Volume and Issue: 123(18), P. 10920 - 10989
Published: Sept. 15, 2023
Anticancer nanomedicines have been proven effective in mitigating the side effects of chemotherapeutic drugs. However, challenges remain augmenting their therapeutic efficacy. Nanomedicines responsive to pathological abnormalities tumor microenvironment (TME) are expected overcome biological limitations conventional nanomedicines, enhance efficacies, and further reduce effects. This Review aims quantitate various TME, which may serve as unique endogenous stimuli for design stimuli-responsive provide a broad objective perspective on current understanding cancer treatment. We dissect typical transport process barriers drug delivery, highlight key principles designed tackle series delivery process, discuss "all-into-one" "one-for-all" strategies integrating needed properties nanomedicines. Ultimately, we insight into future perspectives toward clinical translation
Language: Английский
Citations
81Journal of Controlled Release, Journal Year: 2023, Volume and Issue: 361, P. 212 - 235
Published: Aug. 8, 2023
Language: Английский
Citations
42Journal of environmental chemical engineering, Journal Year: 2024, Volume and Issue: 12(2), P. 112345 - 112345
Published: Feb. 28, 2024
Language: Английский
Citations
22Biomaterials Research, Journal Year: 2023, Volume and Issue: 27(1)
Published: Feb. 9, 2023
With the great success of coronavirus disease (COVID-19) messenger ribonucleic acid (mRNA) vaccines, mRNA therapeutics have gained significant momentum for prevention and treatment various refractory diseases. To function efficiently in vivo overcome clinical limitations, demands safe stable vectors a reasonable administration route, bypassing multiple biological barriers achieving organ-specific targeted delivery mRNA. Nanoparticle (NP)-based systems representing leading vector approaches ensure successful intracellular to target organ. In this review, chemical modifications types advanced NPs, including lipid NPs polymers are summarized. The importance passive targeting, especially endogenous active targeting nano-delivery is emphasized, different cellular endocytic mechanisms discussed. Most importantly, based on above content physiological structure characteristics organs vivo, design strategies cells classified Furthermore, influence routes highlighted. Finally, an outlook remaining challenges future development toward therapies precision medicine provided.
Language: Английский
Citations
32Advanced Science, Journal Year: 2024, Volume and Issue: 11(14)
Published: Jan. 28, 2024
Abstract Intracellular delivery of nano‐drug‐carriers (NDC) to specific cells, diseased regions, or solid tumors has entered the era precision medicine that requires systematic knowledge nano‐biological interactions from multidisciplinary perspectives. To this end, review first provides an overview membrane‐disruption methods such as electroporation, sonoporation, photoporation, microfluidic delivery, and microinjection with merits high‐throughput enhanced efficiency for in vitro NDC delivery. The impact characteristics including particle size, shape, charge, hydrophobicity, elasticity on cellular uptake are elaborated several types systems aiming hierarchical targeting vivo reviewed. Emerging ex human/animal‐derived pathophysiological models further explored highly recommended use studies since they might mimic features fill translational gaps animals humans. exploration modern microscopy techniques precise nanoparticle (NP) tracking at cellular, organ, organismal levels informs tailored development NDCs application clinical translation. Overall, integrates latest insights into smart nanosystem engineering, physiological models, imaging‐based validation tools, all directed towards enhancing efficient intracellular NDCs.
Language: Английский
Citations
13ACS Omega, Journal Year: 2024, Volume and Issue: 9(6), P. 6219 - 6234
Published: Jan. 30, 2024
mRNA, as one of the foci biomedical research in past decade, has become a candidate vaccine solution for various infectious diseases and tumors regenerative medicine immunotherapy due to its high efficiency, safety, effectiveness. A stable effective delivery system is needed protect mRNAs from nuclease degradation while also enhancing immunogenicity. The success mRNA lipid nanoparticles treating COVID-19, certain extent, marks milestone vaccines promotes further on systems. Here, we explore systems, especially (LNPs), considering current status, prospects, challenges nanoparticles, other
Language: Английский
Citations
10Journal of Controlled Release, Journal Year: 2024, Volume and Issue: 366, P. 282 - 296
Published: Jan. 4, 2024
Language: Английский
Citations
9Journal of Hazardous Materials, Journal Year: 2025, Volume and Issue: 490, P. 137792 - 137792
Published: Feb. 28, 2025
Language: Английский
Citations
1Science Bulletin, Journal Year: 2025, Volume and Issue: unknown
Published: March 1, 2025
Language: Английский
Citations
1